AMBIT BIOSCIENCES CORPORATION SECOND WARRANT AMENDMENT AGREEMENT
Exhibit 4.15
AMBIT BIOSCIENCES CORPORATION
SECOND WARRANT AMENDMENT AGREEMENT
This SECOND WARRANT AMENDMENT AGREEMENT (this Amendment) is made as of October 25, 2012, by and among AMBIT BIOSCIENCES CORPORATION, a Delaware corporation (the Company) and the other parties set forth on the signature pages hereto (the Holders), each of whom is a party to either (a) that certain Series D-2 and Series D-3 Preferred Stock and Warrant Purchase Agreement, dated May 9, 2011, by and among the Company and the individuals and entities listed on the Schedule of Purchasers attached thereto (as amended from time to time, the Purchase Agreement) or (b) that certain Subscription Agreement, dated May 17, 2011, by and among the Company, Ambit Biosciences (Canada) Corporation (Ambit Canada) and GrowthWorks Canadian Fund Ltd. (as amended from time to time, the Subscription Agreement).
RECITALS
WHEREAS, Section 12 of each of the warrants issued pursuant to the Purchase Agreement and the Subscription Agreement, as applicable, (collectively, the Warrants) provides that any term of the Warrants may be amended or waived with the written consent of the Company and the holders of at least 60% of the outstanding Shares, including Apposite Healthcare Fund LP (the Requisite Purchasers); and
WHEREAS, the undersigned constitute the Requisite Purchasers and desire to amend the Warrants as set forth herein.
AGREEMENT
NOW, THEREFORE, for good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
1. Section 7 of each Warrant is hereby amended to add the following sentence as the last sentence of such Section 7:
Notwithstanding Section 2(a), in the event the Holder, or any of its Affiliates (as defined in Article IV, Section E.4(n) of the Companys Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware on or about October 26, 2012 (as amended from time to time, the Charter)) becomes a Non-participating Purchaser, Non-participating Holder, Non-participating Canadian Purchaser or Defaulting Preferred Holder (each as defined in the Charter), this Warrant shall immediately terminate.
2. This Amendment may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
3. This Amendment shall be governed by and construed under the laws of the State of California, as applied to agreements among California residents entered into and to be performed entirely within California.
4. Except as specifically amended by this Amendment, all other terms and conditions of the Warrants shall remain in full force and effect in accordance with their terms without modification.
[Remainder of Page Intentionally Left Blank]
2.
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
COMPANY: | ||
AMBIT BIOSCIENCES CORPORATION | ||
Signature: | /s/ Michael A. Martino | |
Print Name: | Michael A. Martino | |
Title: | President and CEO | |
Address: 4215 Sorrento Valley Blvd. San Diego, CA 92121 |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
APPOSITE HEALTHCARE FUND LP | ||
ACTING BY ITS MANAGER, APPOSITE CAPITAL | ||
By: | /s/ A P Marchington | |
Name: | A P Marchington | |
Title: | Partner |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
FORWARD VENTURES IV, L.P. | ||
BY: FORWARD IV ASSOCIATES LLC | ||
AS: GENERAL PARTNER | ||
By: | /s/ Standish Fleming | |
Name: | Standish Fleming | |
Title: | Managing Member | |
FORWARD VENTURES IV B, L.P. | ||
BY: FORWARD IV ASSOCIATES LLC | ||
AS: GENERAL PARTNER | ||
By: | /s/ Standish Fleming | |
Name: | Standish Fleming | |
Title: | Managing Member |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
GENECHEM THERAPEUTICS VENTURE FUND L.P. | ||
By: | /s/ Louis Lacasse | |
Name: | Louis Lacasse | |
Title: | President |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
GROWTHWORKS CANADIAN FUND, LTD. | ||
By: | /s/ Tim Lee | |
Name: | Tim Lee | |
Title: | SVP Investments |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
GIMV NV | ||
By: | /s/ Edmond Bastijns | |
Name: | Edmond Bastijns | |
Title: | GIMV Partner | |
By: | /s/ Koen Dejonckheere | |
Name: | Koen Dejonckheere | |
Title: | CEO | |
ADVIESBEHEER GIMV LIFE SCIENCES 2004 NV | ||
By: | /s/ Edmond Bastijns | |
Name: | Edmond Bastijns | |
Title: | GIMV Partner | |
By: | /s/ Koen Dejonckheere | |
Name: | Koen Dejonckheere | |
Title: | CEO |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
HORIZON TECHNOLOGY FUNDING COMPANY II LLC | ||
By: | /s/ Robert D. Pomeroy, Jr. | |
Name: | Robert D. Pomeroy, Jr. | |
Title: | Chief Executive Officer |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
MEDIMMUNE VENTURES, INC. | ||
By: | /s/ Ron Laufer | |
Name: | Ron Laufer | |
Title: | SR. Managing Director |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
ORBIMED PRIVATE INVESTMENTS III, LP | ||
BY: ORBIMED CAPITAL GP III LLC, ITS GENERAL PARTNER | ||
By: | /s/ Jonathan Silverstein | |
Name: | Jonathan Silverstein | |
Title: | Member | |
ORBIMED ASSOCIATES III, LP | ||
BY: ORBIMED CAPITAL GP III LLC, ITS GENERAL PARTNER | ||
By: | /s/ Jonathan Silverstein | |
Name: | Jonathan Silverstein | |
Title: | Member |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP | ||
By: | /s/ Lloyd Appel | |
Name: | Lloyd Appel | |
Title: | CFO |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
PHARMABIO DEVELOPMENT INC. | ||
By: | /s/ Michael Troullis | |
Name: | Michael Troullis | |
Title: | President |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
RADIUS VENTURE PARTNERS III, L.P. | ||
By: | /s/ Jordan S. Davis | |
Name: | Jordan S. Davis | |
Title: | Managing Member | |
RADIUS VENTURE PARTNERS III QP, L.P. | ||
By: | /s/ Jordan S. Davis | |
Name: | Jordan S. Davis | |
Title: | Managing Member | |
RADIUS VENTURE PARTNERS III (OHIO), L.P. | ||
By: | /s/ Jordan S. Davis | |
Name: | Jordan S. Davis | |
Title: | Managing Member |
[Signature Page to Second Warrant Amendment Agreement]
IN WITNESS WHEREOF, the parties hereto have executed the Amendment as of the date set forth in the first paragraph hereof.
HOLDERS: | ||
ROCHE FINANCE LTD | ||
By: | /s/ Carole Nuechterlein | |
Name: | Carole Nuechterlein | |
Title: | Authorized Signatory | |
By: | /s/ Andreas Knierzinger | |
Name: | Andreas Knierzinger | |
Title: | Authorized Signatory |
[Signature Page to Second Warrant Amendment Agreement]